Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
LBA29 Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC)
I. Ray-Coquard, Alexandra F. Leary, Sandro Pignata, Claire Cropet, A.J. Gonzalez Martin, Gerhard Bogner and 14 more
- Rank
- 98 of 3,616
- Percentile
- top 2.8%
- Where
- Annals of Oncology, 2022
- Citations
- 39
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.